Company: ACBM
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0001640334-25-001257
Chunk: 13

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 1
Chunk 13
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  March 31,  December 31,   2024  2023        ASSETS      Current Assets      Cash $151  $376 Prepaid expenses  -   1,250 Total Current Assets  151   1,626          Operating lease right of use asset  46,041   52,233 Security deposit  4,600   4,600 TOTAL ASSETS $50,792  $58,459          LIABILITIES AND STOCKHOLDERS' DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $152,294  $154,444 Deferred revenue  20,000   20,000 Due to related parties  102,084   88,796 Operating lease liabilities - current  23,402   25,335 Total Current Liabilities  297,780   288,575          Operating lease liabilities - noncurrent  20,324   26,898 TOTAL LIABILITIES  318,104   315,473          Stockholders' Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023  60,042   60,042 Additional paid-in capital  32,299,396   32,298,442 Accumulated deficit  (32,626,750)  (32,615,498)Total Stockholders’ Deficit  (267,312)  (257,014)         TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $50,792  $58,459 

The accompanying notes are an integral part of these unaudited financial statements.

 4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

(Unaudited)

  Three months ended   March 31,   2024  2023        Revenues $-